| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGCCGCCCUUUCCUCUUUCUUUCGCGCUCUAGCCACCCGGGAAGGCCUG… | 1754 nt | 0.3392 | |
| AGCCGCCCUUUCCUCUUUCUUUCGCGCUCUAGCCACCCGGGAAGGCCUG… | 1935 nt | 0.3571 | |
| GCACUUGGCUUCAAAGCUGGCUCUUGGAAAUUGAGCGGAGAGCGACGCG… | 1889 nt | 0.3536 | |
| GCACUUGGCUUCAAAGCUGGCUCUUGGAAAUUGAGCGGAGAGCGACGCG… | 1718 nt | 0.3522 |
The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is a catalytic subunit of the highly conserved protein kinase complex known as M-phase promoting factor (MPF), which is essential for G2/M phase transitions of eukaryotic cell cycle. Mitotic cyclins stably associate with this protein and function as regulatory subunits. The kinase activity of this protein is controlled by cyclin accumulation and destruction through the cell cycle. The phosphorylation and dephosphorylation of this protein also play important regulatory roles in cell cycle control. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2023]
A study in humans demonstrated that the mRNA of the CDK1 was significantly upregulated in salivary extracellular vesicles from both emergency department patients with acute head trauma (p=0.055) and outpatient concussion clinic patients (p=0.006) when compared to healthy controls, with no significant difference between the two patient groups [Cheng et al. DOI:10.1002/jcp.28139]. A study in mice demonstrated that the CDK1 was identified as a top 10 differentially expressed gene and its expression was upregulated in burn tissue based on weighted gene coexpression network analysis [Guo et al. DOI:10.1155/2022/5220403].